Angiogenic Effects of Recombinant Thymosin Beta 4 in a Mouse Hindlimb Ischemia Model
December 2014
in “
Journal of Biomedical Research
”
Studysummary In a mouse model of peripheral vascular disease, this study found that recombinant thymosin β4 treatment increased expression levels of certain proteins, promoting angiogenesis.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jbtr.or.kr →